SCHEMBL22294196

SCHEMBL22294196

CC/C=C/C(O)CC(=O)NC

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 6/20 0.42
LMNA P02545 1/20 0.34
ALDH1A1 P00352 4/20 0.33
MAPT P10636 2/20 0.33
FPR2 P25090 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
OXER1 Q8TDS5 3/20 0.32
FAAH O00519 2/20 0.32
CNR1 P21554 1/20 0.32
ASAH2 Q9NR71 1/20 0.31
FFAR1 O14842 1/20 0.31
CYP19A1 P11511 1/20 0.31
RXRA P19793 1/20 0.31
PPARG P37231 1/20 0.31
MCL1 Q07820 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12352426 0.82 HDAC2 (0.41) HDAC2ALDH1A1MAPTFPR2HDAC3
SCHEMBL10290386 0.81 HDAC2 (0.41) HDAC2LMNAMAPTHDAC3HDAC1
SCHEMBL23879485 0.81 HDAC2 (0.43) HDAC2ALDH1A1MAPTFPR2HDAC3
SCHEMBL12352400 0.80 ALDH1A1 (0.33) LMNAALDH1A1MAPTMCL1
SCHEMBL22294369 0.80 ALDH1A1 (0.33) LMNAALDH1A1MAPTMCL1
SCHEMBL22294481 0.80 ALDH1A1 (0.33) LMNAALDH1A1MAPTMCL1
SCHEMBL22294295 0.80 ALDH1A1 (0.33) LMNAALDH1A1MAPTMCL1
SCHEMBL28579046 0.79 ASAH2 (0.55) HDAC2LMNAALDH1A1MAPTASAH2
SCHEMBL12352401 0.78 KDM4E (0.30)
SCHEMBL6326746 0.77 HDAC2 (0.57) HDAC2LMNAALDH1A1MAPTFPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3786165-A1 SYNTHETIC INTERMEDIATES FOR PRODUCING MACROCYCLES AS FACTOR XIA INHIBITORS Bristol-Myers Squibb Company (US) 2021-03-03 EP disclosed
EP-2534154-B1 MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2020-08-05 EP disclosed